Search All UT System Experts

Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis

Yesenia Gonzalez, Fantine Giap, Peter Klages, Amir Owrangi, Xun Jia, Kevin Albuquerque

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences